Comparison of Inhaled Ciclesonide (640 mcg/Day) and Fluticasone Propionate (1000 mcg/Day) in Patients With Moderate and Severe Persistent Asthma
Comparison of Inhaled Ciclesonide (640 mcg/Day) and Fluticasone Propionate (1000 mcg/Day) in Patients With Moderate and Severe Persistent Asthma
The aim of the study is to compare the safety and efficacy of ciclesonide versus fluticasone propionate on the lung function, symptoms, use of rescue medication, and occurrence of side effects (such as candidiasis, hoarseness) in adults with persistent asthma. Ciclesonide will be inhaled twice daily at one dose level; fluticasone propionate will be inhaled twice daily at one dose level. The study duration consists of a baseline period (2 weeks) and a treatment period (24 weeks). The study will provide further data on safety and tolerability of ciclesonide.
Main Inclusion Criteria:
Main Exclusion Criteria:
Maison-Saint-Gérard, 5640, Belgium
Pirri-Cagliari, 9134, Italy
La Chauxe-de-Fonds, 2300, Switzerland
Chesterfield Derbyshire, S40 4TF, United Kingdom
Co. Antrim, BT38 8TP, United Kingdom
Glengormley Newtownabbey, BT36 5EQ, United Kingdom
Warminster Wiltshire, BA12 9AA, United Kingdom